Frank: One more question, in the near term, what a

Frank: One more question, in the near term, what aspect or positive event or
situation, or change, do you think can bring your share price up to meet the
requirement of five days?

Joe: Oh, I think I have answered that many, many, many times. But let me say it
to you again. When we spin out NuGenerex Immuno-Oncology, that's a huge
asset for us--and it should be public. Generex would be massive shareholder.
So, let's just call 100 million shares, because we haven't figured out the
security structures. Let's just say 100 million shares, Generex who owns that
company, plus still owns 90 percent of the company--even after the dividend
we gave out--and these are hypotheticals, I'm giving you a formula in my
mind.
So, let's say the stock--of course, it's clean, pristine, and it's doing fantastic as
far as all the executables the company is doing right now. Let's just say it's a
$1/share. Well, $1/share at $100 million in value and liquid assets now goes
on Generex's books. I believe it's going to be $100,000 million [?], but I'm
giving you the low, low, low value of what it could be.

With $1 and if it's 100 million shares we own, a $100 million is a liquid asset
on our books, on Generex books. Well, I can only imagine what $100 million
of a liquid asset on Generex book will do to the value of the shares of
Generex. And as that company--as a public company--keeps executing, it
builds our value even more, and more, and more.
So, for me, that is one of the biggest things we can do right now, and that's
why we're working like hell to get that spun out.
That's one thing--I mean there's so many others, but that's one.